FDA Inspection
Todd Bertoch, M.D.Todd Bertoch, M.D. – FDA Inspection, Sep 27, 2024
Record Details
This FDA Inspection record concerns Todd Bertoch, M.D., with an inspection on September 27, 2024, issued by the Denver District Office, covering human drugs.
View Company Profile
ID · ff8a5e49-30e9-463a-9db4-a29273f7ae69
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1250219
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring: Human Drugs
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Todd Bertoch, M.D.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| January 9, 2026 | NAI | Bioresearch Monitoring | |
| December 12, 2022 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Todd Bertoch, M.D.
- FDA Inspection 1301790 - 2026-01-09
- FDA Inspection 1194405 - 2022-12-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.